Decision Investments’s abrdn Life Sciences Investors HQL Stock Holding History

Decision Investments’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$333K	Buy	17,804 +550	+3%	+$11.1K	0.3%	62
2026 Q2	$345K	Sell	17,254 -450	-3%	-$7.95K	0.31%	58
2026 Q1	$288K	Buy	17,704 +50	+0.3%	+$836	0.33%	62
2025 Q4	$296K	Buy	+17,654	New	+$297K	0.32%	56

Other funds holding HQL

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Decision Investments's HQL Position: Q3 2026 in Review

Decision Investments increased its abrdn Life Sciences Investors (HQL) stake by 3.2% in Q3 2026, buying an estimated $11.1K and bringing the position to 17,804 shares worth $333K. The position accounts for 0.3% of the portfolio, ranked #62.

Decision Investments first reported a position in HQL in Q4 2025 and has held it in 4 quarters since. The position peaked at $345K in Q2 2026. 2 funds tracked by Wall St. Rank hold HQL as of Q3 2026.

Decision Investments held 17,804 shares of abrdn Life Sciences Investors worth $333K as of Q3 2026.
Decision Investments bought 550 abrdn Life Sciences Investors shares in Q3 2026, an estimated $11.1K.
abrdn Life Sciences Investors made up 0.3% of Decision Investments's portfolio in Q3 2026, its #62 holding.
Decision Investments first reported a position in abrdn Life Sciences Investors in Q4 2025 and has held it in 4 quarters since.
Decision Investments's abrdn Life Sciences Investors position peaked at $345K in Q2 2026.
2 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.

Based on Decision Investments's 13F filing for Q3 2026, filed 7 Oct 2026.